Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas

Eur J Cancer. 2006 Oct;42(15):2631-8. doi: 10.1016/j.ejca.2006.04.017. Epub 2006 Aug 22.


We characterised the expression of the plasminogen activators (uPA and tPA), the uPA receptor (uPAR) and the PAs inhibitors (PAI-1 and PAI-2) in human thyroid cell lines derived from normal thyroid, follicular adenoma, follicular, papillary and anaplastic carcinomas. Urokinase PA activity was detected in the supernatant of normal thyrocytes and augmented in those of all tumour cells. Quantitative RT-PCR analysis showed that uPA, uPAR and PAI-1 mRNAs increased in all carcinoma cells. Similar results were found in 13 papillary thyroid carcinoma (PTC) tissues which were mirrored in Western blot experiments. A correlation was found between tumour size and uPA mRNA increase, and higher levels of uPA and uPAR mRNAs were found in metastatic PTC. In conclusion, thyroid carcinoma cell lines and PTC overexpress uPA, uPAR and PAI-1 and the correlation of uPA and its cognate receptor with tumour size and metastasis may suggest their potential prognostic relevance in thyroid cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Carcinoma, Papillary / metabolism*
  • Cell Line, Tumor
  • Humans
  • Neoplasm Metastasis
  • Neoplasm Proteins / metabolism*
  • Plasminogen Activators / metabolism*
  • Prognosis
  • RNA, Messenger / metabolism
  • RNA, Neoplasm / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thyroid Neoplasms / metabolism*
  • Urokinase-Type Plasminogen Activator / metabolism


  • Neoplasm Proteins
  • RNA, Messenger
  • RNA, Neoplasm
  • Plasminogen Activators
  • Urokinase-Type Plasminogen Activator